(Q36142376)

12 August 2017

The glucocorticoid receptor N363S polymorphism and steroid response in Duchenne dystrophy (English)

1 reference

12 August 2017

4

E P Hoffman

1 reference

12 August 2017

D M Bonifati

1

1 reference

12 August 2017

S F Witchel

2

1 reference

12 August 2017

M Ermani

3

1 reference

12 August 2017

C Angelini

5

1 reference

12 August 2017

E Pegoraro

6

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 October 2006

1 reference

Journal of Neurology, Neurosurgery and Psychiatry

12 August 2017

1 reference

12 August 2017

77

1 reference

12 August 2017

10

1 reference

12 August 2017

1177-1179

1 reference

Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077532

Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077532

Deflazacort. A review of its pharmacological properties and therapeutic efficacy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077532

The nuclear receptor superfamily: the second decade

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077532

Corticosteroid therapy in Duchenne muscular dystrophy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077532

Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077532

Gene regulation by steroid hormones

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077532

A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077532

Familial glucocorticoid resistance caused by a splice site deletion in the human glucocorticoid receptor gene.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077532

A multicenter, double-blind, randomized trial of deflazacort versus prednisone in Duchenne muscular dystrophy

23 September 2018

1 reference

12 December 2020

Report on the 124th ENMC International Workshop. Treatment of Duchenne muscular dystrophy; defining the gold standards of management in the use of corticosteroids. 2-4 April 2004, Naarden, The Netherlands

1 reference

12 December 2020

Prednisone in Duchenne muscular dystrophy

1 reference

12 December 2020

Loss of strength and functional decline in Duchenne's dystrophy

1 reference

12 December 2020

Clinical investigation of Duchenne muscular dystrophy. Interesting results in a trial of prednisone

1 reference

12 December 2020

Prednisone treatment in Duchenne muscular dystrophy. Long-term benefit

1 reference

12 December 2020

Prednisone in Duchenne dystrophy. A randomized, controlled trial defining the time course and dose response. Clinical Investigation of Duchenne Dystrophy Group

1 reference

12 December 2020

A comparison of daily and alternate-day prednisone therapy in the treatment of Duchenne muscular dystrophy

1 reference

12 December 2020

Long-term benefit from prednisone therapy in Duchenne muscular dystrophy

1 reference

12 December 2020

Duchenne dystrophy: randomized, controlled trial of prednisone (18 months) and azathioprine (12 months)

1 reference

12 December 2020

Deflazacort in Duchenne dystrophy: study of long-term effect

1 reference

12 December 2020

Steroids in muscular dystrophy: where do we stand?

1 reference

12 December 2020

Identifiers

DOI

10.1136/JNNP.2005.078345

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

16980656

1 reference